• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

Curaleaf Raises Bid to Acquire Aurora Cannabis

STAMFORD – Curaleaf Holdings Inc. announced it will file a notice to increase its acquisition offer for Aurora Cannabis Inc. to US$5.00 per share. Under the enhanced terms, Aurora shareholders would receive 0.4013 Curaleaf shares ...

Nasdaq’s $5M Delisting Rule: Frozen, Not Finished

WASHINGTON – The Securities and Exchange Commission (SEC) approved a new Nasdaq listing requirement on July 22, stayed it seven days later after receiving petitions, and on September 11 formally granted those petitions for full ...

Curaleaf Raises Bid to Acquire Aurora Cannabis

STAMFORD – Curaleaf Holdings Inc. announced it will file a notice to increase its acquisition offer for Aurora Cannabis Inc. to US$5.00 per share. Under the enhanced terms, Aurora shareholders would receive 0.4013 Curaleaf shares ...

Delaware Moves to Regulate THC-Infused Beverages

DOVER – Delaware's Senate Banking, Business, Insurance & Technology Committee advanced House Bill 373, sending the measure to the Senate Finance Committee and bringing it a step closer to a full Senate vote. The action ...

Glass House Brands Triggers Warrant Acceleration

LONG BEACH – Glass House Brands Inc., a major player in California Cannabis production and retail, has told holders of warrants issued in two earlier financing rounds that their right to convert those securities into ...

Otsuka Completes $1.23B Buyout of Transcend Therapeutics

PRINCETON – Otsuka America, the U.S. subsidiary of Otsuka Pharmaceutical Co., Ltd., announced that it has completed its acquisition of Transcend Therapeutics, a New York biotechnology company developing rapid-acting treatments for neuropsychiatric disease. First disclosed ...

Glass House Brands Applies for NYSE Uplisting

LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among ...

Optimi Ships Psilocybin to the UK for Phase 2 Trial

VANCOUVER – Optimi Health Corp. announced it has completed its first export of naturally derived psilocybin to the United Kingdom, with the material earmarked for a planned Phase 2 clinical trial whose partner and therapeutic ...

Subscribe To Our Newsletter

Go to Top